had been held up all summer while IDIX and the FDA worked on the design.
Why was it held up? Did IDIX give any indication? FDA indecisiveness? Lack of supporting interraction data? 200 mg or 400 mg?
Were you aware that the FDA and ADAC (antiviral comm.) are convening a special meeting addressing the issues which have surfaced recently with the growing HCV market. See agenda.